PATENT CLAIM ANALYSIS

Application Number: 15742512
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "001890"]

Abstract:
The present invention relates to a method of in vivo imaging and in particular to a method for the evaluation of in vivo images of beta amyloid (Aβ) distribution in the brain of a subject suspected of having Alzheimer's disease (AD). The method of the present invention provides more detailed information to the clinician as compared with prior art methods, facilitating identification of those subjects who will benefit most from disease modifying therapies.

Claim (Index 8):
The method as defined in  claim 1  wherein said A\u03b2 imaging agent is a PET imaging agent.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.47273
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12418177', '14893091', '10388173', '14869862', '12917113']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6953470176140804
- 35 USC 102 Novelty (BERT): 0.5104866671322547
- Combined Prediction Score: 0.6768609825658979
- Mean Citation Score: 216.538076
- Max Citation Score: 240.28098
- Similarity Product: 162.66225718180058

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test